HCP Engagement in Pharma: Strategies We’ve Seen Work

Your CRM captures activity: what was done, how often, and when. But it rarely tells you whether those actions changed the way an HCP thinks or behaves. Why?

Many of the HCP engagement principles we still use today come from a different era where the goal was to get the right message in front of as many doctors as possible, as efficiently as possible.

Today, high-performing teams take a different approach. They design HCP engagement around listening and responding. The goal is to understand where an HCP is in their journey, engage with them, observe what happens, learn from it, and adapt the next interaction accordingly.

In this article, we explore the HCP engagement strategies our teams have tested and refined while working with global life sciences organizations for more than a decade.

Study Your HCP Like a Person, not a Persona

If you view your HCP as Persona 1 or Persona 2, I have bad news for you. HCP preferences, needs, and attitudes are constantly changing. They can’t be squeezed into a rigid category and followed according to a predefined plan. If it’s week 5, then it is the message X.

As Mark Watson from Fractal Force explained on Pharma Talks, effective HCP engagement starts with curiosity: “What are they engaging with? What do they think? What do they want? Where are they starting from, both attitudinally and behaviorally?”

These questions should be answered continuously. That’s what prevents you from starting every conversation from zero or worse, repeating information an HCP has already seen, heard, or simply doesn’t need.

When you understand what an HCP wants from their interactions with you, you can start building the foundation for a trusting relationship. They are more likely to engage, follow up, ask questions, and come back because the interaction starts to feel like a real conversation rather marketing.

Your content should make sense in context: because the HCP asked for it, because it addresses something discussed in a previous interaction, or because it follows up on a webinar they just attended.

Every piece should feel like the next part of the conversation rather than a message that interrupts their busy schedule and competes with other similar messages from other brands.

In other words, your engagement model should follow a loop: learn, engage, observe, learn, adapt, engage again.

Test Strategy Execution Before It Happens

A single rep call can cost up to €150. Multiply that across reps, calls, and markets, and the cost of ineffective execution eats your budget.

Yet, many companies still measure training success by completion. But this approach suffers from a serious drawback. According to Harvard Business Review research, more than 80% of training content is forgotten within 90 days. Completion doesn’t mean retention. And retention doesn’t necessarily mean execution.

Reps need to practice in an environment that resembles the conversations they’ll have using the same approved content they’ll use in the field. AI simulations can let them interact with realistic HCP personas. They can test different approaches, make mistakes, try again, and build confidence before the conversation happens for real.

At the same time, marketers and commercial leaders also need visibility into how their messages perform in these simulated conversations. Which messages resonate? Which content is difficult for reps to explain naturally? These signals can reveal what part of the strategy or the content itself needs change before it reaches the field.

That was the thinking behind our work with CTC Health when building Kheiron. We wanted pharma teams to move beyond training completion as a proxy for readiness and gain a more reliable, helicopter view of how strategy is likely to perform in real-world execution.

A bird-eye view of rep performance across geographies

Respond to the Speed of Modern Engagement

In an AI-everything world, we are no longer obsessing over producing more content. What we are trying to attain is delivering the right content fast enough when an HCP needs it and before competitors or misinformation fill the gap.

Yet, you can’t build responsive HCP engagement on disconnected infrastructure. BCG found that only 1 in 10 biopharma and medtech companies have fully integrated data platforms, while 90% of senior omnichannel leaders cite siloed systems as a major barrier to success.

That means rethinking how the entire content supply chain is orchestrated. Your infrastructure needs to ensure connected content operations, from planning and creation to review, approval, localization, activation, and measurement.

And the supply chain shouldn’t be treated as a linear process. We show it as a circle because content production has no true endpoint. Marketing is an ongoing cycle: we create content, activate it, measure what happens, and feed those insights back into the next round of planning.

The more tightly these “”links of the chain” are connected, the faster those insights can travel through the system and influence the next action. The goal is to create a connected content supply chain where every stage makes the next one more effective. That’s where greater ROI and lower costs come from: optimizing the connections between them rather than optimizing individual steps.

Think About Design When Going Modular

Many teams try modular content and walk away disappointed. Modular is often presented as channel-agnostic and design-free: pure, structured content that lives in the DAM, waiting to be assembled later. But this can leave teams with a library full of modules and no clear way to turn them into a coherent channel experience.

This is one of the biggest reasons why modular content struggles to move beyond the pilot stage. The reality is that the moment a module enters a channel, it inherits a design context. You can divorce content from design conceptually, but you can’t fully separate them operationally.

That’s why the authoring platform matters. It should be able to apply design automatically based on the module’s structure. Standardized, reusable content blocks provide structural logic that tells the platform how each module should be rendered across different channels and formats. In other words, design doesn’t have to live inside every module, but the rules for applying design are important.

Across implementations in our dataset, organizations that establish this foundation have reduced time to market by up to 30%, increased content reuse by more than 50%, and produced up to three times more assets compared with operations before using our platform, eWizard. Content can be assembled, adapted, and deployed without recreating its design and structure for every asset or channel.

Extend Engagement Through DOLs

When patients notice their first symptoms, they no longer necessarily rush to the doctor’s office for evidence-based clinical information. They often turn to ChatGPT, Claude, or other AI tools to make sense of what they are experiencing.

That creates an anchoring effect when the first explanation they encounter can frame how they interpret their symptoms and make them less likely to question what they already believe.

This gives HCPs a new task alongside providing care: counter misinformation before it becomes conviction. To do that, they need to keep a finger on the conversations happening online and be prepared to address the claims and misconceptions patients bring into the consultation.

One way to stay ahead of those conversations is through trusted digital opinion leaders (DOLs). HCPs already turn to peers they trust for credible perspectives, making DOLs a link between scientific evidence and the conversations happening online.

DOLs have the credibility, expertise, and audience to deliver trustworthy information, but often lack the time to create content at the speed social media demands. Pharma can support them with medically approved content kits, evidence-based talking points, and timely content ideas, while leaving enough creative freedom for each DOL to make the message their own.

Done well, this helps HCPs get credible perspectives when they need them, and patients are more likely to encounter reliable information before misinformation becomes their starting point.

Connect Events to Your Channels

Events are often treated as a standalone channel, with success measured by attendance rates and booth traffic. But congresses can and should be a part of your omnichannel engagement. They offer a rare opportunity to learn from HCPs when they have chosen to show up, listen, and engage.

That means capturing consent and engagement in the moment, connecting it to CRM, and using that data to inform what happens next. When these processes are connected, information can flow from one touchpoint to another, making personalized engagement possible.

Let us show how it works using our platform for congress engagement, Lexi. It is a congress engagement ecosystem, spanning identification, engagement, consent, CRM, and activation, that allows teams to avoid asking HCPs for the same information twice or missing opportunities to follow up.

Instead, they can build on what happened at the congress, sending an email that addresses a question the HCP raised, sharing content related to a topic they explored, or continuing a conversation they started at the booth.

Lexi, a congress engagement ecosystem

Engage the Right Way

How many people you reached, who attended an event, or how many completed a training session are important metrics. But they are not the ultimate measure of HCP engagement.

As the saying goes, what gets measured gets done. So, ask yourself: do you simply want more people to know your message, or do you want to influence how HCPs think, engage, and respond to your calls to action?

A behavioral change requires an engagement strategy that can evolve with your HCPs. Understand them. Test your approach. Create and deliver content at the speed they expect. Engage. Measure. Adapt. Then start again.

This cycle helps you build the foundation for more relevant conversations and stronger, long-term HCP relationships.

For more than 17 years, we’ve helped life sciences brands, from global enterprises to growing teams, improve the way they engage HCPs. That experience has taught us that better engagement rarely comes from one more channel or one more technology.

It comes from bringing together life sciences expertise, the right technology ecosystem, and a clear vision for putting both to work.